Your browser doesn't support javascript.
loading
Tezepelumab reduces exacerbations across all seasons in patients with severe, uncontrolled asthma (NAVIGATOR).
Pavord, Ian D; Hoyte, Flavia C L; Lindsley, Andrew W; Ambrose, Christopher S; Spahn, Joseph D; Roseti, Stephanie L; Cook, Bill; Griffiths, Janet M; Hellqvist, Åsa; Martin, Nicole; Llanos, Jean-Pierre; Martin, Neil; Colice, Gene; Corren, Jonathan.
Afiliación
  • Pavord ID; Respiratory Medicine, NIHR Oxford Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom. Electronic address: ian.pavord@ndm.ox.ac.uk.
  • Hoyte FCL; Division of Allergy and Immunology, National Jewish Health, Denver, Colorado.
  • Lindsley AW; US Medical Affairs, Amgen, Thousand Oaks, California.
  • Ambrose CS; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland.
  • Spahn JD; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Wilmington, Delaware.
  • Roseti SL; Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.
  • Cook B; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland.
  • Griffiths JM; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.
  • Hellqvist Å; Biometrics, Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Martin N; Biometrics, Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Waltham, Massachusetts; Cytel Inc., Waltham, Massachusetts.
  • Llanos JP; Global Medical Affairs, Amgen, Thousand Oaks, California.
  • Martin N; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, United Kingdom.
  • Colice G; Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.
  • Corren J; David Geffen School of Medicine, University of California, Los Angeles, California.
Ann Allergy Asthma Immunol ; 131(5): 587-597.e3, 2023 11.
Article en En | MEDLINE | ID: mdl-37619779
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Asma / Antiasmáticos Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Aged80 / Child / Humans / Middle aged Idioma: En Revista: Ann Allergy Asthma Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Asma / Antiasmáticos Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Aged80 / Child / Humans / Middle aged Idioma: En Revista: Ann Allergy Asthma Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos